Package 0591-0395-01

{"route": ["ORAL"], "spl_id": "cd137b2d-e092-4c37-8c12-ea1ac6297451", "openfda": {"unii": ["F850569PQR", "A36BXO4PPX"], "rxcui": ["312289"], "spl_set_id": ["a28450a0-ac93-4235-b9a6-58cdf24773cb"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (0591-0395-01)", "package_ndc": "0591-0395-01", "marketing_start_date": "19970521"}], "brand_name": "Pentazocine and naloxone", "product_id": "0591-0395_cd137b2d-e092-4c37-8c12-ea1ac6297451", "dosage_form": "TABLET", "pharm_class": ["Competitive Opioid Antagonists [MoA]", "Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist/Antagonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "0591-0395", "dea_schedule": "CIV", "generic_name": "Pentazocine hydrochloride and naloxone hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pentazocine and naloxone", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".5 mg/1"}, {"name": "PENTAZOCINE HYDROCHLORIDE", "strength": "50 mg/1"}], "application_number": "ANDA074736", "marketing_category": "ANDA", "marketing_start_date": "19970521", "listing_expiration_date": "20271231"}